155 related articles for article (PubMed ID: 17642249)
1. [Pneumonia, pneumocystis pneumonia].
Koike R; Harigai M
Nihon Rinsho; 2007 Jul; 65(7):1314-20. PubMed ID: 17642249
[TBL] [Abstract][Full Text] [Related]
2. Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis.
Koike R; Takeuchi T; Eguchi K; Miyasaka N;
Mod Rheumatol; 2007; 17(6):451-8. PubMed ID: 18084695
[TBL] [Abstract][Full Text] [Related]
3. [Treatment guidelines for the use of biologics in rheumatoid arthritis; present and future].
Miyasaka N; Koike R
Nihon Rinsho; 2007 Jul; 65(7):1169-78. PubMed ID: 17642228
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients.
Komano Y; Harigai M; Koike R; Sugiyama H; Ogawa J; Saito K; Sekiguchi N; Inoo M; Onishi I; Ohashi H; Amamoto F; Miyata M; Ohtsubo H; Hiramatsu K; Iwamoto M; Minota S; Matsuoka N; Kageyama G; Imaizumi K; Tokuda H; Okochi Y; Kudo K; Tanaka Y; Takeuchi T; Miyasaka N
Arthritis Rheum; 2009 Mar; 61(3):305-12. PubMed ID: 19248121
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors.
Tanaka M; Sakai R; Koike R; Komano Y; Nanki T; Sakai F; Sugiyama H; Matsushima H; Kojima T; Ohta S; Ishibe Y; Sawabe T; Ota Y; Ohishi K; Miyazato H; Nonomura Y; Saito K; Tanaka Y; Nagasawa H; Takeuchi T; Nakajima A; Ohtsubo H; Onishi M; Goto Y; Dobashi H; Miyasaka N; Harigai M
Mod Rheumatol; 2012 Nov; 22(6):849-58. PubMed ID: 22354637
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis Jirovecii Pneumonia in Japanese Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Pooled Analysis of 3 Agents.
Tanaka M; Sakai R; Koike R; Harigai M
J Rheumatol; 2015 Sep; 42(9):1726-8. PubMed ID: 26330129
[No Abstract] [Full Text] [Related]
7. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
[TBL] [Abstract][Full Text] [Related]
8. Pneumocystis pneumonia associated with infliximab in Japan.
Harigai M; Koike R; Miyasaka N;
N Engl J Med; 2007 Nov; 357(18):1874-6. PubMed ID: 17978303
[No Abstract] [Full Text] [Related]
9. Pneumocystis jiroveci pneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor alpha neutralizing antibody.
Mori S; Imamura F; Kiyofuji C; Ito K; Koga Y; Honda I; Sugimoto M
Mod Rheumatol; 2006; 16(1):58-62. PubMed ID: 16622728
[TBL] [Abstract][Full Text] [Related]
10. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
11. Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
van Dartel SA; Fransen J; Kievit W; Flendrie M; den Broeder AA; Visser H; Hartkamp A; van de Laar MA; van Riel PL
Ann Rheum Dis; 2013 Jun; 72(6):895-900. PubMed ID: 22887849
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety.
Komano Y; Tanaka M; Nanki T; Koike R; Sakai R; Kameda H; Nakajima A; Saito K; Takeno M; Atsumi T; Tohma S; Ito S; Tamura N; Fujii T; Sawada T; Ida H; Hashiramoto A; Koike T; Ishigatsubo Y; Eguchi K; Tanaka Y; Takeuchi T; Miyasaka N; Harigai M;
J Rheumatol; 2011 Jul; 38(7):1258-64. PubMed ID: 21498482
[TBL] [Abstract][Full Text] [Related]
13. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.
Dixon WG; Watson K; Lunt M; Hyrich KL; Silman AJ; Symmons DP;
Arthritis Rheum; 2006 Aug; 54(8):2368-76. PubMed ID: 16868999
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series.
Jarrett SJ; Cunnane G; Conaghan PG; Bingham SJ; Buch MH; Quinn MA; Emery P
J Rheumatol; 2003 Oct; 30(10):2287-91. PubMed ID: 14528531
[TBL] [Abstract][Full Text] [Related]
15. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
Gómez-Reino JJ; Carmona L; Valverde VR; Mola EM; Montero MD;
Arthritis Rheum; 2003 Aug; 48(8):2122-7. PubMed ID: 12905464
[TBL] [Abstract][Full Text] [Related]
16. [Monitoring of clinical course in TNF inhibitor treatment for rheumatoid arthritis--efficacy evaluation, adverse effect detection, and prediction of clinical response].
Yamamura M
Nihon Rinsho; 2007 Jul; 65(7):1269-75. PubMed ID: 17642242
[TBL] [Abstract][Full Text] [Related]
17. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
[TBL] [Abstract][Full Text] [Related]
18. [A case of pulmonary nontuberculous mycobacteriosis aggravated during treatment with etanercept for rheumatoid arthritis].
Esaki T; Sugimoto M; Mori S; Yamashita A; Matsumoto M; Kohrogi H
Nihon Kokyuki Gakkai Zasshi; 2010 Apr; 48(4):312-6. PubMed ID: 20432974
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.
Hyrich KL; Silman AJ; Watson KD; Symmons DP
Ann Rheum Dis; 2004 Dec; 63(12):1538-43. PubMed ID: 15242866
[TBL] [Abstract][Full Text] [Related]
20. [Two cases of respiratory infection complicating treatment with infliximab].
Kasai S; Tokuda H; Otsuka Y; Ookohchi Y; Handa H; Emoto N; Yoshikawa M
Nihon Kokyuki Gakkai Zasshi; 2007 Apr; 45(4):366-71. PubMed ID: 17491318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
